The DOI matches its Crossref record; 264 of the 264 references it cites were found in a registry or an index.
Mouse and human FcR effector functions
Abstract
Summary: Mouse and human FcRs have been a major focus of attention not only of the scientific community, through the cloning and characterization of novel receptors, and of the medical community, through the identification of polymorphisms and linkage to disease but also of the pharmaceutical community, through the identification of FcRs as targets for therapy or engineering of Fc domains for the generation of enhanced therapeutic antibodies. The availability of knockout mouse lines for every single mouse FcR, of multiple or cell‐specific—‘à la carte’—FcR knockouts and the increasing generation of hFcR transgenics enable powerful in vivo approaches for the study of mouse and human FcR biology. This review will present the landscape of the current FcR family, their effector functions and the in vivo models at hand to study them. These in vivo models were recently instrumental in re‐defining the properties and effector functions of FcRs that had been overlooked or discarded from previous analyses. A particular focus will be made on the (mis)concepts on the role of high‐affinity IgG receptors in vivo and on results from antibody engineering to enhance or abrogate antibody effector functions mediated by FcRs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–264 of 264
Peanut-induced intestinal allergy is mediated through a mast cell–IgE–FcεRI–IL-13 pathway
Wang, M., Takeda, K., Shiraishi, Y., Okamoto, M., Dakhama, A., Joetham, A., & Gelfand, E. W. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.05.017 · Cited by 79
Tsuboi, N., Ernandez, T., Li, X., Nishi, H., Culleré, X., Mekala, D. J., Hazen, M. M., Köhl, J., Lee, D. M., & Mayadas, T. N. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30141 · Cited by 78
syk protein tyrosine kinase regulates Fc receptor γ‐chain‐mediated transport to lysosomes
Bonnerot, C., Briken, V., Brachet, V., Lankar, D., Cassard, S., Jabrì, B., & Amigorena, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4606 · Cited by 78
Bai, Y., Ye, L., Tesar, D. B., Song, H., Zhao, D., Björkman, P. J., Roopenian, D. C., & Zhu, X. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115348108 · Cited by 76
Involvement of Toso in activation of monocytes, macrophages, and granulocytes
Lang, K. S., Lang, P. A., Meryk, A., Pandyra, A. A., Boucher, L.-M., Pozdeev, V. I., Tusche, M. W., Göthert, J. R., Haight, J., Wakeham, A. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222264110 · Cited by 75
Quayle, J. A., WATSON, F., Bucknall, R. C., & Edwards, S. W. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.00249.x · Cited by 73
Jankovic, D. L., Kullberg, M. C., Dombrowicz, D., Barbieri, S., Caspar, P., Wynn, T. A., Paul, W. E., Cheever, A. W., Kinet, J., & Sher, A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.4.1868 · Cited by 72
Stolla, M., Stefanini, L., André, P., Ouellette, T. D., Reilly, M. P., McKenzie, S. E., & Bergmeier, W. (2011) · Blood · doi:10.1182/blood-2011-03-342352 · Cited by 72
Lejeune, J., Thibault, G., Ternant, D., Cartron, G., Watier, H., & Ohresser, M. C. P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.4118 · Cited by 70
Enhanced humoral immune responses against T-independent antigens in Fcα/μR-deficient mice
Honda, S.-I., Kurita, N., Miyamoto, A., Cho, Y., Usui, K., Takeshita, K., Takahashi, S., Yasui, T., Kikutani, H., Kinoshita, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809917106 · Cited by 70
Petkova, S. B., Konstantinov, K. N., Sproule, T. J., Lyons, B. L., Al-Awwami, M. A., & Roopenian, D. C. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051951 · Cited by 70
Bandukwala, H. S., Clay, B. S., Tong, J., Mody, P. D., Cannon, J. L., Shilling, R. A., Verbeek, J. S., Weinstock, J. V., Solway, J., & Sperling, A. I. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061134 · Cited by 68
Syed, S. N., Konrad, S., Wiege, K., Nieswandt, B., Nimmerjahn, F., Schmidt, R. E., & Gessner, J. E. (2009) · European Journal of Immunology · doi:10.1002/eji.200939884 · Cited by 67
Intracellular antibody‐mediated immunity and the role of TRIM21
McEwan, W. A., Mallery, D. L., Rhodes, D. A., Trowsdale, J., & James, L. C. (2011) · BioEssays · doi:10.1002/bies.201100093 · Cited by 67
Unusual biochemical features and follicular dendritic cell expression of human Fcα/μ receptor
Kikuno, K., Kang, D., Tahara, K., Torii, I., Kubagawa, H. M., Ho, K. J., Baudino, L., Nishizaki, N., Shibuya, A., & Kubagawa, H. (2007) · European Journal of Immunology · doi:10.1002/eji.200737655 · Cited by 67
Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity
Bournazos, S., Chow, S.-K., Abboud, N., Casadevall, A., & Ravetch, J. V. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72676 · Cited by 66
Palaniyandi, S., Tomei, E., Li, Z., Conrad, D. H., & Zhu, X. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002146 · Cited by 66
Reconstitution of human Fc gamma RIII cell type specificity in transgenic mice.
Li, M. Y., Wirthmueller, U., & Ravetch, J. V. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.3.1259 · Cited by 65
Moldt, B., Schultz, N., Dunlop, D. C., Alpert, M. D., Harvey, J. D., Evans, D. T., Poignard, P., Hessell, A. J., & Burton, D. R. (2011) · Journal of Virology · doi:10.1128/jvi.05541-11 · Cited by 65
van der Poel, C. E., Karssemeijer, R. A., Boross, P., van der Linden, J. A., Blokland‐Fromme, M., van de Winkel, J. G. J., & Leusen, J. H. W. (2010) · Blood · doi:10.1182/blood-2010-04-280214 · Cited by 64
Sesărman, A., Sitaru, A. G., Olaru, F., Zillikens, D., & Sitaru, C. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0366-7 · Cited by 64
Hamre, R., Farstad, I. N., Brandtzaeg, P., & Morton, H. C. (2003) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2003.01220.x · Cited by 63
Alleles of the Ly-17 alloantigen define polymorphisms of the murine IgG Fc receptor.
Holmes, K. L., Palfree, R. G. E., Hämmerling, U., & Morse, H. C. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.22.7706 · Cited by 62
MacGlashan, D. W. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1313.009 · Cited by 59
Murthy, A. K., Dubose, C. N., Banas, J. A., Coalson, J. J., & Arulanandam, B. P. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04312.x · Cited by 59
CD64-Directed Immunotoxin Inhibits Arthritis in a Novel CD64 Transgenic Rat Model
van Vuuren, A. J., van Roon, J. A. G., Walraven, V., Stuij, I., Harmsen, M. C., McLaughlin, P. M. J., van de Winkel, J. G. J., & Thepen, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.5833 · Cited by 57
Targeting Weak Antigens to CD64 Elicits Potent Humoral Responses in Human CD64 Transgenic Mice
Keler, T., Guyre, P. M., Vitale, L. A., Sundarapandiyan, K., van de Winkel, J. G. J., Deo, Y. M., & Graziano, R. F. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.6738 · Cited by 57
Fc receptor inside‐out signaling and possible impact on antibody therapy
Brandsma, A. M., Jacobino, S. R., Meyer, S., ten Broeke, T., & Leusen, J. H. W. (2015) · Immunological Reviews · doi:10.1111/imr.12332 · Cited by 57
Taylor, S. M., Reilly, M. P., Schreiber, A. D., Chien, P., Tuckosh, J. R., & McKenzie, S. E. (2000) · Blood · doi:10.1182/blood.v96.13.4254 · Cited by 56
Haczku, A., Takeda, K., Hamelmann, E. H., et al. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.6.9701087 · Cited by 55
Clynes, R. (2006) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2006.02.010 · Cited by 54
CD3 and Immunoglobulin G Fc Receptor Regulate Cerebellar Functions
Nakamura, K., Hirai, H., Torashima, T., Miyazaki, T., Tsurui, H., Xiu, Y., Ohtsuji, M., Lin, Q. S., Tsukamoto, K., Nishimura, H., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01072-06 · Cited by 53
Latour, S., Fridman, W. H., & Daëron, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.1.189 · Cited by 52
Dutertre, C., Gélizé, E., Pulford, K. A. F., Bourel, D., Fridman, W. H., & Teillaud, J. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0608343 · Cited by 52
Tan, P. S., Gavin, A. L., Barnes, N. C., Sears, D. W., Vremec, D., Shortman, K., Amigorena, S., Mottram, P. L., & Hogarth, P. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2549 · Cited by 51
Physiologic assessment of allergic rhinitis in mice: Role of the high-affinity IgE receptor (FcɛRI)
Miyahara, S., Miyahara, N., Takeda, K., Joetham, A., & Gelfand, E. W. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.08.020 · Cited by 51
Structural Difference in the Complement Activation Site of Human IgG1 and IgG3
Michaelsen, T. E., Sandlie, I., Bratlie, D. B., Sandin, R., & Ihle, Ø. (2009) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2009.02338.x · Cited by 50
Allergen-IgE Complexes Trigger CD23-Dependent CCL20 Release From Human Intestinal Epithelial Cells
Li, H., Chehade, M., Liu, W., Xiong, H., Mayer, L., & Berin, M. C. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.024 · Cited by 49
Mittal, R., Sukumaran, S. K., Selvaraj, S. K., Wooster, D. G., Babu, M. M., Schreiber, A. D., Verbeek, J. S., & Prasadarao, N. V. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001203 · Cited by 45
Inhibition of destructive autoimmune arthritis in FcγRIIa transgenic mice by small chemical entities
Pietersz, G. A., Mottram, P. L., van de Velde, N. C., Sardjono, C. T., Esparon, S. E., Ramsland, P. A., Moloney, G. M., Baell, J. B., McCarthy, T. D., Matthews, B. R., et al. (2008) · Immunology and Cell Biology · doi:10.1038/icb.2008.82 · Cited by 44
Antibody-Mediated Trapping of Helminth Larvae Requires CD11b and Fcγ Receptor I
Bieren, J. E., Volpe, B., Kulagin, M., Sutherland, D. B., Guiet, R., Seitz, A., Marsland, B. J., Verbeek, J. S., & Harris, N. L. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401645 · Cited by 44
Destructive Arthritis in the Absence of Both FcγRI and FcγRIII
Boross, P., van Lent, P. L., Martín-Ramírez, J., van der Kaa, J., Mulder, M. H. C. M., Claassens, J. W. C., van den Berg, W. B., Arandhara, V. L., & Verbeek, J. S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.5083 · Cited by 43
Fcγ receptors enable anticancer action of proapoptotic and immune-modulatory antibodies
Kim, J. M., & Ashkenazi, A. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20131625 · Cited by 43
Saylor, C., Dadachova, E., & Casadevall, A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902752 · Cited by 41
Williams, E. L., Tutt, A. L., French, R. R., Chan, H. T. C., Lau, B., Penfold, C. A., Mockridge, C. I., Roghanian, A., Cox, K. L., Verbeek, J. S., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201142302 · Cited by 41
van Egmond, M., van Vuuren, A. J. H., & van de Winkel, J. G. J. (1999) · Immunology Letters · doi:10.1016/s0165-2478(99)00034-6 · Cited by 41
Antitumor IgE Adjuvanticity: Key Role of FcεRI
Nigro, E. A., Brini, A. T., Soprana, E., Ambrosi, A., Dombrowicz, D., Siccardi, A. G., & Vangelista, L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900842 · Cited by 39
Araujo, L. M. M., Chauvineau, A., Zhu, R., Diem, S., Bourgeois, E. A., Levescot, A., Huerre, M., Gombert, J., Bayry, J., Daëron, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003076 · Cited by 37
Self-citationWilliams, E. L., Tutt, A. L., Beers, S. A., French, R. R., Chan, H. T. C., Cox, K. L., Roghanian, A., Penfold, C. A., Butts, C. L., Boross, P., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301430 · Cited by 36
Dombrowicz, D., Nutten, S., Desreumaux, P., Neut, C., Torpier, G., Peeters, M., Colombel, J., & Capron, M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.193.1.25 · Cited by 35
Albanesi, M., Mancardi, D. A., Macdonald, L. E., Iannascoli, B., Zitvogel, L., Murphy, A. J., Leusen, J. H. W., & Bruhns, P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201511 · Cited by 35
Self-citationvan de Velde, N. C., Mottram, P. L., Powell, M. S., Lim, B., Holmdahl, R., & Hogarth, P. M. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.12.005 · Cited by 33
Čemerski, S., Chu, S. Y., Moore, G. L., Muchhal, U. S., Desjarlais, J. R., & Szymkowski, D. E. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.01.008 · Cited by 29
FcεRI and FcγRIII/CD16 Differentially Regulate Atopic Dermatitis in Mice
Abboud, G., Staumont-Sallé, D., Kanda, A., Roumier, T., Deruytter, N., Lavogiez, C., Fleury, S., Rémy, P., Papin, J.-P., Capron, M., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801055 · Cited by 29
Nakamura, A., Nukiwa, T., & Takai, T. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00034-9 · Cited by 26
Yoo, E. M., Trinh, K. R., Lim, H., Wims, L. A., & Morrison, S. L. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.05.011 · Cited by 23
Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP?
Crow, A. R., Song, S. M., Suppa, S. J., Ma, S., Reilly, M. P., André, P., McKenzie, S. E., & Lazarus, A. H. (2010) · Blood · doi:10.1182/blood-2010-05-280115 · Cited by 23
Inefficient antigen presentation via the IgA Fc receptor (FcαRI) on dendritic cells
Otten, M. A., Groenveld, I., van de Winkel, J. G. J., & van Egmond, M. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.05.016 · Cited by 20
Sharp, P. E. H., Martín-Ramírez, J., Mangsbo, S. M., Boross, P., Pusey, C. D., Touw, I. P., Cook, H. T., Verbeek, J. S., & Tarzi, R. M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202250 · Cited by 20
Human Fcα/μR and pIgR distribute differently in intestinal tissues
Wang, R., Fu, Y., Zhao, Q., Pan, L., & Zhang, W. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.176 · Cited by 19
CpG oligodeoxynucleotides enhance Fc RI-mediated cross presentation by dendritic cells
Bevaart, L. (2004) · International Immunology · doi:10.1093/intimm/dxh110 · Cited by 17
Human neutrophils express the high‐affinity receptor for immunoglobulin E (FceRI): role in asthma
GOUNNI, A. S., Lamkhioued, B., Latifa, K., Ra, C., RENZI, P. M., & Hamid, Q. A. (2001) · The FASEB Journal · doi:10.1096/fsb2fj000378com · Cited by 16
IgG Fc receptor polymorphisms and association with autoimmune disease
Andrén, M., Johanneson, B., Alarcón-Riquelme, M. E., & Kleinau, S. (2005) · European Journal of Immunology · doi:10.1002/eji.200526291 · Cited by 12
The MHC class I-related FcRn ameliorates murine Lyme arthritis
Crowley, H., Alroy, J., Sproule, T. J., Roopenian, D. C., & Huber, B. T. (2006) · International Immunology · doi:10.1093/intimm/dxh380 · Cited by 8
Cited by
Translational Applications of Hydrogels
Correa, S., Grosskopf, A. K., Lopez Hernandez, H., Chan, D., Yu, A. C., Stapleton, L. M., & Appel, E. A. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01177 · Cited by 1,143
Neutrophils as emerging therapeutic targets
Németh, T., Sperandio, M., & Mócsai, A. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0054-z · Cited by 653
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation
Junqueira, C., Crespo, Â., Ranjbar, S., de Lacerda, L. B., Lewandrowski, M., Ingber, J., Parry, B., Ravid, S., Clark, S., Schrimpf, M. R., et al. (2022) · Nature · doi:10.1038/s41586-022-04702-4 · Cited by 631
The CD47‐SIRPα signaling axis as an innate immune checkpoint in cancer
Matlung, H. L., Szilagyi, K., Barclay, N. A., & van den Berg, T. K. (2017) · Immunological Reviews · doi:10.1111/imr.12527 · Cited by 557
Wang, S., Mustafa, M., Yuede, C. M., Salazar, S. V., Kong, P., Long, H., Ward, M., Siddiqui, O., Paul, R., Gilfillan, S., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200785 · Cited by 549
Metadata
- Authors
- Bruhns, P., & Jönsson, F.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2015-10-26
- Volume
- 268
- Issue
- 1
- Pages
- 25-51
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W1862569453
- Cited by
- 579
- References
- 264
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.